back to top
HomeTagsAscentage

Ascentage

Reside from ASCO 2024 | Ascentage Pharma Releases Up to date Information of FAK/ALK/ROS1 Inhibitor APG-2449 in Sufferers with NSCLC By Investing.com

SUZHOU, China, and ROCKVILLE, Md., June 1, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a worldwide biopharmaceutical firm engaged in creating novel therapies for most...

Most Popular

spot_img